Assessment of serum level of insulin-like growth factor 1 in the Blood of gastric cancer patients
Not Applicable
- Conditions
- Gastric cancer.Stomach, unspecified
- Registration Number
- IRCT2016080318745N10
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Inclusion criteria include: 40-70 years old patients with dyspepsia; the patients with written consent; the patients with no history of cancer or special disease.
Exclusion criteria include: the patients with diabetes type 1 or 2; the patients with obesity; the patients with smoking.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum level assessment of insulin-like growth factor I. Timepoint: after endoscopy procedure. Method of measurement: Elizza.
- Secondary Outcome Measures
Name Time Method The expression of the genes involved in insulin-like growth factor 1 signaling pathway. Timepoint: One time after sampling. Method of measurement: Real-time PCR.